1. Home
  2. IH vs MOLN Comparison

IH vs MOLN Comparison

Compare IH & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IH
  • MOLN
  • Stock Information
  • Founded
  • IH 1996
  • MOLN 2004
  • Country
  • IH China
  • MOLN Switzerland
  • Employees
  • IH N/A
  • MOLN N/A
  • Industry
  • IH Other Consumer Services
  • MOLN
  • Sector
  • IH Real Estate
  • MOLN
  • Exchange
  • IH Nasdaq
  • MOLN Nasdaq
  • Market Cap
  • IH 146.3M
  • MOLN 142.6M
  • IPO Year
  • IH 2020
  • MOLN 2021
  • Fundamental
  • Price
  • IH $3.07
  • MOLN $3.64
  • Analyst Decision
  • IH
  • MOLN Hold
  • Analyst Count
  • IH 0
  • MOLN 1
  • Target Price
  • IH N/A
  • MOLN $4.00
  • AVG Volume (30 Days)
  • IH 18.1K
  • MOLN 5.1K
  • Earning Date
  • IH 09-22-2025
  • MOLN 11-05-2025
  • Dividend Yield
  • IH 2.85%
  • MOLN N/A
  • EPS Growth
  • IH N/A
  • MOLN N/A
  • EPS
  • IH 0.26
  • MOLN N/A
  • Revenue
  • IH $123,701,096.00
  • MOLN $856,302.00
  • Revenue This Year
  • IH $39.02
  • MOLN N/A
  • Revenue Next Year
  • IH N/A
  • MOLN $1,000.00
  • P/E Ratio
  • IH $11.26
  • MOLN N/A
  • Revenue Growth
  • IH N/A
  • MOLN N/A
  • 52 Week Low
  • IH $1.47
  • MOLN $3.36
  • 52 Week High
  • IH $3.60
  • MOLN $7.60
  • Technical
  • Relative Strength Index (RSI)
  • IH 60.00
  • MOLN 48.03
  • Support Level
  • IH $2.80
  • MOLN $3.69
  • Resistance Level
  • IH $3.16
  • MOLN $3.79
  • Average True Range (ATR)
  • IH 0.16
  • MOLN 0.13
  • MACD
  • IH 0.03
  • MOLN 0.00
  • Stochastic Oscillator
  • IH 85.40
  • MOLN 18.18

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: